Tpot and head and neck cancer: Where are we now?

Anticancer Research

Volumn 18, Issue 6 B, 1998, Pages 4801-4805

  Wilson, George D ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Head and neck cancer; Tpot

Indexed keywords

BROXURIDINE;

ACCURACY; CANCER GROWTH; CANCER RADIOTHERAPY; CELL PROLIFERATION; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; REPRODUCIBILITY; REVIEW;

CELL CYCLE; CELL DIVISION; HEAD AND NECK NEOPLASMS; HUMANS; KINETICS; PROGNOSIS;

EID: 0032441533     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Suit HD: Potential for improving the survival rate for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer 50: 1227-1234, 1982.
2. Leibel SA, Scott CB, Mohiuddin M, Marcial VA, Coia LR, Davis LW and Fuks Z: The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 21: 549-556, 1991.
3. Fowler JF and Lindstrom M: Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23: 457-467, 1992.
4. Fowler JF, Tanner MA, Bataini JP, Asselain B, Bernier J, Lave C: Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 19: 237-244, 1990
5. Taylor JM, Withers HR, Mendenhall WM: Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 17: 95-102, 1 990.
6. Withers HR, Taylor JMG and Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27: 131-146, 1988.
7. Peters LJ, Ang KK and Thames HD: Accelerated fractionation in the treatment of head and neck cancer: a critical comparison of different strategies. Acta Oncol 27: 185-194, 1988.
8. Saunders MI, Dische S, Grosch E, Fermont DC, Ashford RFU, Maher J and Makepeace AR: Experience with CHART. Int J Radiat Oncol Biol Phys 21: 871-878, 1991.
9. Horiot JC, Bontemps P, van den Bogaert W, Le Fur R, van den Weijngaert D, Bolla M, Bemier J, Lusinchi A, Stuschke M, Lopez-Torrecilla J, Begg AC, Pierart M, Collette L: Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44: 111-121, 1997.
10. Tubiana M, Courdi A: Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 15: 1-18, 1989.
11. Gratzner HG: Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218: 474-475, 1982.
12. Dolbeare F, Gratzner H, Pallavicini MG, Gray JW: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine Proc Natl Acad Sci USA 80: 5573-5577, 1983.
13. Wilson GD, McNally NJ, Dunphy E, Karcher H, Pfragner R: The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 6: 641-647, 1985.
14. Raza A, Ucar K, Preisler HD: Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia. Cytometry 6: 633-640, 1985.
15. Hoshino T, Nagashima T, Murovic J, Levin EM, Levin VA, Rupp SM: Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6: 627-632, 1985.